▲ SURGE

Biorestorative Therapies Inc.

+73.3%
BRTXNASDAQHealthcare2026-05-27
0.433
收盘价
0.25
前收盘价
+73.30%
涨幅
47.6x
量比

暴涨原因

2026년 2월 10일, BioRestorative Therapies는 만성 요추 디스크 질환 치료제 BRTX-100의 임상 2상 시험 환자 등록 완료를 발표했다.

  • ·2026년 2월 10일, BioRestorative Therapies는 만성 요추 디스크 질환 치료제 BRTX-100의 임상 2상 시험 환자 등록 완료를 발표했다.
  • ·2026년 2월 12일, BioRestorative Therapies는 500만 달러 규모의 주식 공모(stock offering) 가격을 책정했다.

相关新闻

BioRestorative shares are trading lower. The company announced completion of patient enrollment in its Phase 2 clinical trial evaluating BRTX-100 for the treatment of chronic lumbar disc disease. - BioRestorative Therapies (NASDAQ:BRTX)
Benzinga2026-02-10
BioRestorative prices $5M stock offering (BRTX:NASDAQ)
Seekingalpha2026-02-12
NRx Pharmaceuticals, Inc. (NRXP) Stock Price, News, Quote & History
Ca.Finance.Yahoo2026-03-07
United Therapeutics Authorized New Stock Repurchase Program Of Up To $2B - United Therapeutics (NASDAQ:UTHR)
Benzinga2026-03-09
XORTX Therapeutics shares are trading higher after the company announced it delayed its 1-for-5 shares consolidation. - XORTX Therapeutics (NASDAQ:XRTX)
Benzinga2026-03-26

技术分析

信号
布林上轨突破超买MACD看涨站上SMA20
关键指标
80.33RSI (14)
0.22SMA 20
0.11Bollinger Lower
0.33Bollinger Upper
0.22Bollinger Mid
0.01MACD
-0.01MACD Signal
0.02MACD Hist
查看股票详情返回暴涨股列表
Biorestorative Therapies Inc. +73.3% 暴涨分析 (2026-05-27) | Alpha Lenz